HIPAA Alert: Potential Data Breach. Learn More

Research Institute

Screening Study to determine biomarker status for patients with malignant tumors

Master Screening Study to determine biomarker status and potential trial eligibility for patients with malignant tumors

Disease Types: Lung

Available at: AlleghanyBlacksburgRoanokeSalemWytheville

Master Screening Study to determine biomarker status and potential trial eligibility for patients with malignant tumors

For More Information:

https://clinicaltrials.gov/ct2/show/NCT05419375?term=Master+Screening+Study+to+determine+biomarker+status+and+potential+trial+eligibility+for+patients+with+malignant+tumors&draw=2&rank=1